Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
Further Understanding of the Immunopathology of Multiple Sclerosis: Impact on Future Treatments.
Histamine and Immune Biomarkers in CNS Disorders.
Cortical functional modifications following optic neuritis.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
Olfactory dysfunction in patients with multiple sclerosis.
Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis.
A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland.
Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.
Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment.
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.
Cross-disease transcriptomics: Unique IL-17A signaling in psoriasis lesions and an autoimmune PBMC signature.
Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS).
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.
Newly Identified Gait Patterns in Patient With Multiple Sclerosis May Be Related to Push-Off Quality.
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground.

Pages